Arrowhead Pharmaceuticals (ARWR) Short Interest Ratio & Short Volume → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free ARWR Stock Alerts $24.44 +0.31 (+1.28%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Arrowhead Pharmaceuticals Short Interest DataCurrent Short Volume8,870,000 sharesPrevious Short Volume8,870,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$212.97 millionShort Interest Ratio / Days to Cover7.1Last Record DateApril 15, 2024Outstanding Shares123,900,000 sharesPercentage of Shares Shorted7.16%Today's Trading Volume630,822 sharesAverage Trading Volume903,610 sharesToday's Volume Vs. Average70% Short Selling Arrowhead Pharmaceuticals ? Sign up to receive the latest short interest report for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatARWR Short Interest Over TimeARWR Days to Cover Over TimeARWR Percentage of Float Shorted Over Time Ad Weiss RatingsThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. Arrowhead Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20248,870,000 shares $212.97 million No ChangeN/A7.1 $24.01 3/31/20248,870,000 shares $253.68 million -3.6%N/A6.2 $28.60 3/15/20249,200,000 shares $260.18 million +4.1%N/A5.8 $28.28 2/29/20248,840,000 shares $283.76 million +0.8%N/A5.5 $32.10 2/15/20248,770,000 shares $259.33 million +13.6%N/A5.4 $29.57 1/31/20247,720,000 shares $247.81 million -13.0%N/A5 $32.10 Get the Latest News and Ratings for ARWR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20248,870,000 shares $323.13 million +18.7%8.8%5.8 $36.43 12/31/20237,470,000 shares $228.58 million -3.5%7.4%5 $30.60 12/15/20237,740,000 shares $220.98 million +1.6%7.7%6.3 $28.55 11/30/20237,620,000 shares $161.54 million -3.3%7.5%6.5 $21.20 11/15/20237,880,000 shares $212.84 million +9.9%7.8%7.9 $27.01 10/31/20237,170,000 shares $176.31 million +0.6%7.1%7.5 $24.59 10/15/20237,130,000 shares $189.66 million +19.0%7.0%7.5 $26.60 9/30/20235,990,000 shares $160.95 million -1.8%5.9%6.6 $26.87 9/15/20236,100,000 shares $176.41 million -3.6%6.0%6.7 $28.92 8/31/20236,330,000 shares $174.96 million +4.5%6.3%7.1 $27.64 8/15/20236,060,000 shares $177.86 million +8.8%6.0%6.8 $29.35 7/31/20235,570,000 shares $192.28 million +8.0%5.5%6.1 $34.52 7/15/20235,160,000 shares $178.54 million +9.3%5.0%5.2 $34.60 6/30/20234,720,000 shares $168.32 million -5.4%4.6%4.6 $35.66 6/15/20234,990,000 shares $178.34 million +1.0%4.9%5 $35.74 5/31/20234,940,000 shares $169.99 million -5.5%4.8%4.4 $34.41 5/15/20235,230,000 shares $208.62 million +8.1%5.1%4.5 $39.89 4/30/20234,840,000 shares $171.38 million -0.8%4.7%4.2 $35.41 4/15/20234,880,000 shares $148.64 million -1.6%4.7%4.7 $30.46 3/31/20234,960,000 shares $125.98 million -9.8%4.8%4.5 $25.40 3/15/20235,500,000 shares $139.26 million +19.1%5.3%4.9 $25.32 2/28/20234,620,000 shares $149.23 million -2.5%4.4%4.7 $32.30 2/15/20234,740,000 shares $161.40 million +3.5%4.6%4.9 $34.05 1/31/20234,580,000 shares $160.25 million -0.7%4.5%4.4 $34.99 1/15/20234,610,000 shares $169.74 million -2.7%4.5%4.6 $36.82 12/30/20224,740,000 shares $192.25 million +11.8%4.6%5 $40.56 12/15/20224,240,000 shares $133.31 million +7.1%4.2%4.8 $31.44 11/30/20223,960,000 shares $127.51 million +6.2%3.8%4.6 $32.20 11/15/20223,730,000 shares $125.55 million -4.4%3.6%4.5 $33.66 10/31/20223,900,000 shares $135.76 million -1.0%3.8%5 $34.81 10/15/20223,940,000 shares $126.16 million +1.8%3.9%5.1 $32.02 9/30/20223,870,000 shares $127.90 million -9.2%3.8%5.1 $33.05 9/15/20224,260,000 shares $149.65 million +1.9%4.2%5.4 $35.13 8/31/20224,180,000 shares $165.99 million -4.4%4.1%5.2 $39.71FW: 234x Gain (Ad)This coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. ARWR Short Interest - Frequently Asked Questions What is Arrowhead Pharmaceuticals' current short interest? Short interest is the volume of Arrowhead Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 8,870,000 shares of ARWR short. Learn More on Arrowhead Pharmaceuticals' current short interest. What is a good short interest ratio for Arrowhead Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ARWR shares currently have a short interest ratio of 7.0. Learn More on Arrowhead Pharmaceuticals's short interest ratio. Which institutional investors are shorting Arrowhead Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Arrowhead Pharmaceuticals: Concourse Financial Group Securities Inc., Simplex Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. How does Arrowhead Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Arrowhead Pharmaceuticals: Summit Therapeutics Inc. (27.60%), ACADIA Pharmaceuticals Inc. (6.76%), Janux Therapeutics, Inc. (9.99%), Amicus Therapeutics, Inc. (10.57%), Merus (5.61%), MorphoSys AG (1.02%), MoonLake Immunotherapeutics (15.38%), IDEAYA Biosciences, Inc. (14.86%), Xenon Pharmaceuticals Inc. (3.47%), PTC Therapeutics, Inc. (13.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Arrowhead Pharmaceuticals stock? Short selling ARWR is an investing strategy that aims to generate trading profit from Arrowhead Pharmaceuticals as its price is falling. ARWR shares are trading up $0.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Arrowhead Pharmaceuticals? A short squeeze for Arrowhead Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ARWR, which in turn drives the price of the stock up even further. How often is Arrowhead Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARWR, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SMMT Short Squeeze ACAD Short Squeeze JANX Short Squeeze FOLD Short Squeeze MRUS Short Squeeze MOR Short Squeeze MLTX Short Squeeze IDYA Short Squeeze XENE Short Squeeze PTCT Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ARWR) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry